PA
ARRY icon

PharVision Advisers’s Array Technologies ARRY Stock Holding History

PharVision Advisers’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-89,560
Closed -$730K – 698
2025
Q3 		$730K Buy
+89,560
New +$678K 0.41% 4

Other funds holding ARRY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCC
Hill City Capital Boston, Massachusetts $2.8B AUM 79.27% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

PharVision Advisers's ARRY Position: Q4 2025 in Review

PharVision Advisers sold out of Array Technologies (ARRY) in Q4 2025, closing a stake of 89,560 shares — an estimated $730K sold.

PharVision Advisers first reported a position in ARRY in Q3 2025 and held it in 1 quarter. The position peaked at $730K in Q3 2025. 286 funds tracked by Wall St. Rank hold ARRY as of Q4 2025.

  • PharVision Advisers reported no remaining Array Technologies position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 89,560 Array Technologies shares in Q4 2025, an estimated $730K.
  • PharVision Advisers first reported a position in Array Technologies in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's Array Technologies position peaked at $730K in Q3 2025.
  • 286 funds tracked by Wall St. Rank held Array Technologies as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.